Stay informed with the Sun Pharma Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of ...

Sun Pharmaceutical Industries Ltd is quoting at Rs 1914.2, up 0.07% on the day as on 12:44 IST on the NSE. The stock is up 14.45% in last one year as compared to a 4.11% fall in NIFTY and a 16.43% ...

Sun Pharma expects to close the acquisition on or before 31 July 2026.

Stock of Sun Pharmaceutical is in focus as the company’s shares are set to turn ex- dividend tomorrow with its final dividend ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Indian markets surged for a third straight day, buoyed by global sentiment and strong performance from heavyweight stocks ...

Join us on the Sun Pharma Stock Liveblog, your hub for real-time updates and comprehensive analysis on a prominent stock.

After navigating a series of manufacturing problems in recent months, Sun Pharma has now been forced to respond to an entirely different type of issue. Last week, Mumbai, India-based Sun Pharma ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Sun Pharma and Sun Pharma Advanced Research obtained the Food and Drug Administration’s nod for Sezaby (phenobarbital sodium powder for injection) for the treatment of neonatal seizures. Sezaby is the ...

Sun Pharma announced Thursday morning that it is acquiring Concert Pharmaceuticals for $576 million. The Indian-based pharma company will acquire all outstanding shares of the late-stage biotech that ...

Specialty generics company Sun Pharma has completed the merger of Taro. As part of this merger, Sun Pharma acquired all outstanding ordinary shares of Taro other than the shares already held by Sun ...